OR WAIT null SECS
The new center will primarily support SAFC’s biopharmaceutical development and manufacturing clients in Asia.
Sigma Aldrich announced on Apr. 17, 2015 that the company is opening a new technical center to service its biopharmaceutical clients looking to develop their research and production capacities.
"The development and manufacturing of biologics, whether innovative new products or generic versions of existing drugs (biosimilars), continues to be an attractive area of growth as our customers continue pushing the boundaries of science and advancing their ability to treat and cure disease," said Jason Apter, vice-president and managing director, Asia Pacific for Sigma-Aldrich, in a press release.
The center will specifically provide cell culture media and optimization service, as well as preclinical media manufacturing for customized production of non-cGMP batches of materials.
Sigma-Aldrich also said it also has plans in the works to open its own cGMP distribution center in Tuas, Singapore, and this facility is expected to open at the end of 2015.